No items found.
MangoRx brings a unique product to the GLP-1 market with Slim, a compounded oral semaglutide orally dissolvable tablet (ODT) that eliminates the need for injections. The citrus-flavored daily tablet includes Vitamin B6 to help reduce common GLP-1 side effects like nausea. At $299/month, the pricing is moderate for a needle-free option. As a publicly traded company on NASDAQ (ticker: MGRX), MangoRx operates under greater financial transparency and regulatory scrutiny than many private telehealth startups.
The needle-free ODT format is a genuine differentiator for patients who are uncomfortable with or unable to self-inject. The inclusion of Vitamin B6 in the formulation shows thoughtful product design aimed at reducing side effects. Being publicly traded provides a layer of corporate accountability and financial transparency. The daily dosing schedule of 1-6mg provides gradual titration flexibility. MangoRx also offers tirzepatide for patients who may benefit from dual-action GLP-1/GIP treatment.
The most significant concern is the near-total absence of customer reviews. With only 1 Trustpilot review, there is virtually no independent patient feedback to evaluate the real-world experience. MangoRx is primarily a men's health company (ED, hair loss, testosterone) that has diversified into weight loss, raising questions about their depth of expertise in weight management. Eli Lilly filed a lawsuit against the company in October 2024 regarding their compounded tirzepatide product, which introduces legal uncertainty. The website and marketing materials are less developed compared to established GLP-1 telehealth competitors.
MangoRx is an intriguing option for patients specifically seeking a needle-free oral GLP-1 tablet. The publicly traded status provides some accountability, but the lack of customer reviews and ongoing litigation are notable concerns. Best for patients who prioritize avoiding injections and are comfortable being early adopters of a newer weight loss offering from an established health brand.
MangoRx Slim, their oral semaglutide dissolvable tablet for weight loss, costs $299 per month for a 30-day supply. The price includes a virtual consultation with a licensed provider and the medication shipped to your home. They also offer compounded tirzepatide, though pricing for that option is less prominently listed.
MangoRx Slim is a needle-free orally dissolvable tablet (ODT) that you place on your tongue daily. The citrus-flavored tablet dissolves without water and contains compounded semaglutide with added Vitamin B6 to help reduce nausea. Dosing ranges from 1mg to 6mg, with gradual increases over time.
MangoRx is operated by Mangoceuticals Inc., a publicly traded company on NASDAQ under the ticker MGRX. The company was founded in 2021 and is headquartered in Dallas, Texas. Being publicly traded means the company is subject to SEC reporting requirements and financial oversight. However, they have very limited customer reviews available online.
MangoRx offers Slim, their signature compounded oral semaglutide ODT, and compounded tirzepatide. The Slim tablet is their primary weight loss product and is designed as a needle-free alternative to injectable GLP-1 medications. Brand-name GLP-1s like Wegovy or Zepbound are not currently offered.
MangoRx currently has very limited customer review data, with only 1 review on Trustpilot as of early 2025. The company is relatively new to the weight loss market, having expanded from their core men's health product line. This lack of independent feedback makes it difficult to fully evaluate the patient experience compared to more established GLP-1 telehealth providers.
